Clinical Trials Browser

Terminated × Uterine Neoplasms × pembrolizumab × Clear all

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase EARLY_PHASE1 Terminated

Uterine Neoplasms, Endometrial Neoplasms